Biostage, Inc. (BSTG) financial statements (2021 and earlier)

Company profile

Business Address 84 OCTOBER HILL ROAD
HOLLISTON, MA 01746
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 114375
Cash and cash equivalents 114375
Restricted cash and investments 00    
Receivables   0000
Inventory, net of allowances, customer advances and progress billings     00
Inventory     00
Prepaid expense 0000 0
Other current assets 0000  
Other undisclosed current assets 00(0) 00
Total current assets: 124386
Noncurrent Assets
Operating lease, right-of-use asset 0
Property, plant and equipment 001111
Total noncurrent assets: 101111
TOTAL ASSETS: 235597
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 001100
Accounts payable  01100
Accrued liabilities 00    
Employee-related liabilities 0     
Other undisclosed accounts payable and accrued liabilities 00    
Debt 0     
Derivative instruments and hedges, liabilities 0001  
Due to related parties   0  0
Other undisclosed current liabilities 000100
Total current liabilities: 112311
Noncurrent Liabilities
Long-term debt and lease obligation 0     
Operating lease, liability 0
Total noncurrent liabilities: 0     
Total liabilities: 112311
Stockholders' equity
Stockholders' equity attributable to parent, including: 123286
Common stock 000000
Additional paid in capital 655850383319
Accumulated other comprehensive income (loss)     (0)0
Accumulated deficit (64)(56)(48)(36)(25)(13)
Other undisclosed stockholders' equity attributable to parent   1   
Total stockholders' equity: 123286
TOTAL LIABILITIES AND EQUITY: 235597

Income statement (P&L) ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues    000
Cost of revenue    (0)(0)(0)
Gross profit:    (0)(0)0
Operating expenses (9)(8)(11)(12)(12)(11)
Operating loss: (9)(8)(11)(12)(12)(11)
Nonoperating income (expense) 10(0)1(0)(0)
Other nonoperating income (expense)  (0)(0)1  
Interest and debt expense    (0)  
Other undisclosed income from continuing operations before equity method investments, income taxes    0  
Net loss available to common stockholders, diluted: (8)(8)(12)(12)(12)(11)

Comprehensive Income ($ in millions)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (8)(8)(12)(12)(12)(11)
Other comprehensive income (loss)    0(0)(0)
Comprehensive loss: (8)(8)(12)(12)(12)(11)
Other undisclosed comprehensive income, net of tax, attributable to parent      0
Comprehensive loss, net of tax, attributable to parent: (8)(8)(12)(12)(12)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: